Skip to main content

eHealth Ontario is cancelling its contract to set up a diabetes registry.

Greg Reed, president of eHealth, confirmed Tuesday that notice of termination has been sent to CGI Information Systems and Management Consultants Inc.

A resolution passed by the eHealth board of directors on Sept. 5 had recommended terminating the $46.2-million agreement to build a diabetes registry.

Story continues below advertisement

CGI and eHealth announced the six-year deal on Aug. 9, 2010 for the company to design, build and maintain the registry to better monitor diabetes patients.

Spokesman Robert Mitchell has said no money has been spent on the unfinished registry, and alleged CGI had regularly missed development deadlines.

Health Minister Deb Matthews says she supports the decision by eHealth to cancel the contract, noting it protects taxpayers from $46-million in spending.

"The Ontario Diabetes Strategy continues to be implemented, including ensuring that every person with diabetes in Ontario who wants a family doctor has access to one," Matthews said.

"I am working in partnership with diabetes advocates, like the Canadian Diabetes Association, to ensure that the electronic component of the Ontario Diabetes Strategy best serves the needs of people with the disease," she said.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter